Prevalence of persistent pain after breast cancer treatment by detection mode among participants in population-based screening programs

Anabel Romero, Isabel Torà-Rocamora, Marisa Baré, Teresa Barata, Laia Domingo, Joana Ferrer, Núria Torà, Mercè Comas, Carmen Merenciano, Francesc Macià, Xavier Castells, Maria Sala, CAMISS Study Group, Anabel Romero, Isabel Torà-Rocamora, Marisa Baré, Teresa Barata, Laia Domingo, Joana Ferrer, Núria Torà, Mercè Comas, Carmen Merenciano, Francesc Macià, Xavier Castells, Maria Sala, CAMISS Study Group

Abstract

Background: To date, the study of the risks and benefits of breast cancer screening has not included the onset of persistent pain after breast cancer treatment within the context of population-based screening programs. Our purpose was to investigate the prevalence of persistent pain and associated factors in women diagnosed with breast cancer (screening or interval) in the context of a population-based breast cancer screening program in Spain.

Methods: A total of 1,057 women participating in a population-based breast cancer screening program were diagnosed with breast cancer between 2000 and 2008. The women were treated surgically and followed-up to 2013. The risk of developing persistent pain was estimated through multivariate logistic regression analysis.

Results: Breast cancer was detected during routine screening in 732 women (69.3 %) and emerged as an interval cancer between two screening rounds in 325 (30.7 %). Persistent pain was present in 118 women (11.3 %). Women diagnosed through routine screening reported a higher prevalence of persistent pain (12.9 %) than those with interval cancers (7.8 %)(P < 0.05). Multivariate logistic regression analysis identified two other variables associated with persistent pain: having a Charlson index > =2 (Odds Ratio [OR]: 4.5 95 % Confidence Interval [CI]: 2.1-9.5) versus no comorbidities, and having undergone an axillary lymph node dissection (OR: 2.0 95 % CI: 1.0-4.0) versus sentinel lymph node biopsy.

Conclusions: The prevalence of persistent pain was relatively low. The detection mode was not related to the onset of persistent pain. The factors associated with persistent pain were a Charlson index > =2 and the performance of axillary lymph node dissection. Women treated for breast cancer are at risk for developing persistent pain regardless of the detection mode, especially those with comorbidities and those who have undergone axillary lymph node dissection.

Keywords: Breast cancer; Comorbidities; Complications; Interval cancer; Persistent pain; Screening.

References

    1. Fact Sheets by Population [Internet]. [cited 2016 Jul 1]. Available from:
    1. Irvin VL, Kaplan RM. Screening mammography & breast cancer mortality: meta-analysis of quasi-experimental studies. PLoS One. 2014;9(6):e98105. doi: 10.1371/journal.pone.0098105.
    1. Domingo L, Salas D, Zubizarreta R, Baré M, Sarriugarte G, Barata T, et al. Tumor phenotype and breast density in distinct categories of interval cancer: results of population-based mammography screening in Spain. Breast Cancer Res BCR. 2014;16(1):R3. doi: 10.1186/bcr3595.
    1. Andersen KG, Kehlet H. Persistent pain after breast cancer treatment: a critical review of risk factors and strategies for prevention. J Pain Off J Am Pain Soc. 2011;12(7):725–46. doi: 10.1016/j.jpain.2010.12.005.
    1. Schou Bredal I, Smeby NA, Ottesen S, Warncke T, Schlichting E. Chronic pain in breast cancer survivors: comparison of psychosocial, surgical, and medical characteristics between survivors with and without pain. J Pain Symptom Manage. 2014;48(5):852–62. doi: 10.1016/j.jpainsymman.2013.12.239.
    1. De Oliveira GS, Chang R, Khan SA, Hansen NM, Khan JH, McCarthy RJ, et al. Factors associated with the development of chronic pain after surgery for breast cancer: a prospective cohort from a tertiary center in the United States. Breast J. 2014;20(1):9–14. doi: 10.1111/tbj.12207.
    1. Bruce J, Thornton AJ, Powell R, Johnston M, Wells M, Heys SD, et al. Psychological, surgical, and sociodemographic predictors of pain outcomes after breast cancer surgery: a population-based cohort study. Pain. 2014;155(2):232–43. doi: 10.1016/j.pain.2013.09.028.
    1. Bell RJ, Robinson PJ, Nazeem F, Panjari M, Fradkin P, Schwarz M, et al. Persistent breast pain 5 years after treatment of invasive breast cancer is largely unexplained by factors associated with treatment. J Cancer Surviv Res Pract. 2014;8(1):1–8. doi: 10.1007/s11764-013-0306-6.
    1. Belfer I, Schreiber KL, Shaffer JR, Shnol H, Blaney K, Morando A, et al. Persistent postmastectomy pain in breast cancer survivors: analysis of clinical, demographic, and psychosocial factors. J Pain Off J Am Pain Soc. 2013;14(10):1185–95. doi: 10.1016/j.jpain.2013.05.002.
    1. Mejdahl MK, Andersen KG, Gärtner R, Kroman N, Kehlet H. Persistent pain and sensory disturbances after treatment for breast cancer: six year nationwide follow-up study. BMJ. 2013;346:f1865. doi: 10.1136/bmj.f1865.
    1. Sheridan D, Foo I, O’Shea H, Gillanders D, Williams L, Fallon M, et al. Long-term follow-up of pain and emotional characteristics of women after surgery for breast cancer. J Pain Symptom Manage. 2012;44(4):608–14. doi: 10.1016/j.jpainsymman.2011.10.021.
    1. Alves Nogueira Fabro E, Bergmann A, do Amaral E, Silva B, Padula Ribeiro AC, de Souza Abrahão K, da Costa Leite Ferreira MG, et al. Post-mastectomy pain syndrome: incidence and risks. Breast Edinb Scotl. 2012;21(3):321–5. doi: 10.1016/j.breast.2012.01.019.
    1. Ewertz M, Jensen AB. Late effects of breast cancer treatment and potentials for rehabilitation. Acta Oncol Stockh Swed. 2011;50(2):187–93. doi: 10.3109/0284186X.2010.533190.
    1. Miaskowski C, Cooper B, Paul SM, West C, Langford D, Levine JD, et al. Identification of patient subgroups and risk factors for persistent breast pain following breast cancer surgery. J Pain Off J Am Pain Soc. 2012;13(12):1172–87. doi: 10.1016/j.jpain.2012.09.013.
    1. Li YYO, Kong SK. Persistent pain after breast cancer surgery in a Chinese population. Clin J Pain. 2011;27(6):481–5. doi: 10.1097/AJP.0b013e31820e12b1.
    1. Sipilä R, Estlander A-M, Tasmuth T, Kataja M, Kalso E. Development of a screening instrument for risk factors of persistent pain after breast cancer surgery. Br J Cancer. 2012;107(9):1459–66. doi: 10.1038/bjc.2012.445.
    1. Gärtner R, Jensen M-B, Nielsen J, Ewertz M, Kroman N, Kehlet H. Prevalence of and factors associated with persistent pain following breast cancer surgery. JAMA. 2009;302(18):1985–92. doi: 10.1001/jama.2009.1568.
    1. Redondo M, Funez R, Medina-Cano F, Rodrigo I, Acebal M, Tellez T, et al. Detection methods predict differences in biology and survival in breast cancer patients. BMC Cancer. 2012;12:604. doi: 10.1186/1471-2407-12-604.
    1. Mook S, Veer LJ V’t, Rutgers EJ, Ravdin PM, van de Velde AO, van Leeuwen FE, et al. Independent prognostic value of screen detection in invasive breast cancer. J Natl Cancer Inst. 2011;103(7):585–97. doi: 10.1093/jnci/djr043.
    1. Ascunce N, Salas D, Zubizarreta R, Almazán R, Ibáñez J, Ederra M, et al. Cancer screening in Spain. Ann Oncol Off J Eur Soc Med Oncol ESMO. 2010;21(Suppl 3):iii43-51.
    1. Perry N, Broeders M, de Wolf C, Törnberg S, Holland R, von Karsa L. European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition--summary document. Ann Oncol Off J Eur Soc Med Oncol ESMO. 2008;19(4):614–22. doi: 10.1093/annonc/mdm481.
    1. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83. doi: 10.1016/0021-9681(87)90171-8.
    1. Goldhirsch A, Wood WC, Coates AS, Gelber RD, Thürlimann B, Senn H-J, et al. Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol Off J Eur Soc Med Oncol ESMO. 2011;22(8):1736–47. doi: 10.1093/annonc/mdr304.
    1. Lyman GH, Giuliano AE, Somerfield MR, Benson AB, Bodurka DC, Burstein HJ, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol Off J Am Soc Clin Oncol. 2005;23(30):7703–20. doi: 10.1200/JCO.2005.08.001.
    1. Classification of Chronic Pain, Second Edition (Revised) - IASP [Internet]. [cited 2016 Jun 22]. Available from:
    1. Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain Lond Engl. 2006;10(4):287–333. doi: 10.1016/j.ejpain.2005.06.009.
    1. Hickey OT, Nugent NF, Burke SM, Hafeez P, Mudrakouski AL, Shorten GD. Persistent pain after mastectomy with reconstruction. J Clin Anesth. 2011;23(6):482–8. doi: 10.1016/j.jclinane.2011.01.009.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi